2- GM. Role of insulin resistance in human disease. Banding Lecture. Diabetes 1988; 37: 12, 1595-1607.
Alexander CM, Landsman PB, Teutsch SM, etal NCEP defined metabolic syndrome, diabetes and prevalence of
coronary heart disease among NHANES+++ participants age 50 years and older. Diabetes 2003; 52: 1210- 1214.
Alberti G. Introduction to the metabolic syndrome. Eur Heart J2005; 7: D3- D5.
3 Despres JP, Lemieux I. Abdominal obesity and metabolic syndrome.Nature 2006;444:881–887.
4-Lawlor DA, Smith GD, Ebrahim S. Does the new International Diabetes Federation definition of the metabolic
syndrome predict CHD any more strongly than older definitions? Findings from the British Women's Heart and Health Study. Diabetologia 2006; 49:41.
5. Meigs JB, Rutter MK, Sullivan LM, et al. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular
disease in people with metabolic syndrome. Diabetes Care 2007; 30:1219.
6. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program - Adult Treatment Panel
III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as
predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007; 30:8.
7-Dekker JM, Girman C, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM,Heine RJ. Metabolic syndrome and 10-year
cardiovascular disease risk inthe Hoorn Study. Circulation 2005; 112:666–673.
8. Bo S, Gentile L, Ciccone G, Baldi C, Benini L, Dusio F, Lucia C,Forastiere G, Nuti C, Cassader M, Franco Pagano
G. The metabolicsyndrome and high C-reactive protein: prevalence and differences by sexin a southern-European
population-based cohort. Diabetes Metab ResRev. 2005; 21:515–524.
9-Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Bonadonna RC,Muggeo M. Bruneck Study. Metabolic
syndrome: epidemiology andmore extensive phenotypic description. Cross-sectional data from theBruneck Study. Int J
ObesRelatMetabDisord. 2003; 27:1283–1289.
10-Miccoli R, Bianchi C, Odoguardi L, Penno G, Caricato F, GiovannittiMG, Pucci L, Del Prato S. Prevalence of the
metabolic syndrome amongItalian adults according to ATP III definition. Nutr Metab Cardiovasc Dis. 2005; 15:250 –
254.
11-Maggi S, Noale M, Gallina P, Bianchi D, Marzari C, Limongi F, CrepaldiG; ILSA Working Group. Metabolic
syndrome, diabetes, and cardiovasculardisease in an elderly Caucasian cohort: the Italian LongitudinalStudy on Aging.
J Gerontol A BiolSci Med Sci. 2006; 61:505–510.
12-Lorenzo C, Serrano-Rios M, Martinez- Larrad MT, Gonzalez-Sanchez JL,Seclen S, Villena A, GonzalezVillalpando C, Williams K, HaffnerSM.Geographic variations of the International Diabetes Federation and theNational
Cholesterol Education Program- Adult Treatment Panel III definitionsof the metabolic syndrome in nondiabetic
subjects. DiabetesCare 2006; 29:685– 691
13-Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive
patients who have average or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac
Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentrerandomised controlled trial. Lancet 2003; 361:
1149–58.
14-NCEP Expert Panel on the Detection and Treatment of High Blood Cholesterol in Adults (ATP III). Third Report of
the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106:3143- 421.
15-Grundy SM, Cleeman JI, Merz CN, et al.Implications of recent clinical trials for the National Cholesterol Education
Program Adult Treatment Panel III guidelines.
16-Elissa Lane Miller, CNM, PhD, Angela Mitchell, FNP, ND. Metabolic Syndrome: Screening, Diagnosis, and
Management. J. Midwif& Women’s Health2006; 51(3) 141- 151.
16-Ballantyne CM, Olsson AG, Cook TJ, et al. Influence of low high-density lipoprotein cholesterol and elevated
triglyceride on coronary heart disease events and response to simvastatin therapy in 4S. Circulation 2001; 104:3046.
139. Pyörälä K, Ballantyne CM, Gumbiner B, et
17-Lakka TA, Laaksonen DE. Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol
Nutr Metab 2007; 32: 76- 88. 9. Bate KL, Jerums G. Preventing complications of diabetes. Med J Aust. 2003; 179(9):
498-503. 10.
18-Karter AJ, Ferrara A, Darbinian JA, Ackerson LM, Selby JV. Self-monitoring of blood glucose: language and
financial barriers in a managed care population with diabetes. Diabetes Care 2000; 23(4): 477-83. 11.
19-Siminerio LM, Piatt GA, Emerson S, Ruppert K, Saul M, Solano F, et al. Deploying the chronic care model to
implement and sustain diabetes self- management training programs. Diabetes Educ 2006; 32(2): 253-60.